Featured 13F manager
Patient Capital Management, LLC Samantha McLemore
Baltimore, MD 19 processed 13Fs on this site · 2021 Q4–2026 Q2
- $3.1B
- 39 Positions
- 2026 Q2
- +11.5% QoQ
- Top 5 30.5%
Portfolio
top 5 30.5% · top 10 51.3%
- RPRX - Royalty Pharma · CLASS A 6.6%
- C - Citigroup 6.4%
- GOOGL - Alphabet · CL A 6.2%
- UNH - Unitedhealth Group 6.0%
- AMZN - Amazon 5.3%
- NVDA - Nvidia 4.6%
- CVS - Cvs Health 4.2%
- NCLH - Norwegian Cruise Line 4.2%
- QXO - QXO Inc 4.0%
- ET - Energy Transfer L P 3.8%
- IAC - People 3.7%
- PGEN - Precigen 3.6%
- Other 41.4%
AUM over time
Book
| GOOGL - Alphabet · CL A | 3.08% | Hold | 3,685 | $2,897 | $11M |
| META - Meta Platforms · CL A | 3.04% | Hold | 31,400 | $336.34 | $11M |
| NCLH - Norwegian Cruise | 3.04% | Hold | 508,800 | $20.74 | $11M |
| DXC - Dxc Technology | 3.00% | Hold | 323,700 | $32.19 | $10M |
| DAL - Delta Air Lines Del | 2.74% | Hold | 243,000 | $39.08 | $9M |
| GM - General Mtrs | 2.66% | Hold | 157,400 | $58.63 | $9M |
| OVV - Ovintiv | 2.63% | Hold | 270,575 | $33.70 | $9M |
| Tivity Health | 2.62% | Hold | 344,400 | $26.44 | $9M |
| BABA - Alibaba Group | 2.61% | Hold | 76,200 | $118.79 | $9M |
| MAT - Mattel | 2.51% | Hold | 403,700 | $21.56 | $9M |
| Farfetch · CL A | 2.49% | Hold | 258,400 | $33.43 | $9M |
| ADT - ADT Del | 2.36% | Hold | 974,800 | $8.41 | $8M |
| BHC - Bausch Health Cos | 2.31% | Hold | 290,300 | $27.61 | $8M |
| FANG - Diamondback Energy | 2.30% | Hold | 74,000 | $107.85 | $8M |
| Avid Technology | 2.13% | Hold | 227,300 | $32.57 | $7M |
| Herbalife Nutrition | 2.13% | Hold | 180,800 | $40.93 | $7M |
| TMHC - Taylor Morrison Home | 2.05% | Hold | 203,600 | $34.96 | $7M |
| FISV - Fiserv | 1.96% | Hold | 65,600 | $103.80 | $7M |
| Splunk | 1.92% | Hold | 57,700 | $115.72 | $7M |
| JPM - Jpmorgan Chase & | 1.82% | Hold | 39,900 | $158.35 | $6M |
| UBER - UBER Technologies | 1.81% | Hold | 149,800 | $41.93 | $6M |
| TEVA - Teva Pharmaceutical Inds | 1.73% | Hold | 749,900 | $8.01 | $6M |
| Quotient Technology | 1.72% | Hold | 806,000 | $7.42 | $6M |
| Ww Intl | 1.67% | Hold | 358,800 | $16.13 | $6M |
| ET - Energy Transfer L P | 1.65% | Hold | 697,000 | $8.23 | $6M |
| OMF - Onemain | 1.52% | Hold | 105,400 | $50.04 | $5M |
| VNT - Vontier | 1.43% | Hold | 161,800 | $30.73 | $5M |
| COF - Capital One Finl | 1.26% | Hold | 30,100 | $145.08 | $4M |
| Tupperware Brands | 1.25% | Hold | 283,100 | $15.29 | $4M |
| AMZN - Amazon | 1.15% | Hold | 1,200 | $3,334 | $4M |
| RKT - Rocket Cos · CL A | 1.14% | Hold | 282,800 | $14.00 | $4M |
| BAC - Bank of America | 1.13% | Hold | 87,900 | $44.49 | $4M |
| SOFI - SOFI Technologies | 0.88% | Hold | 193,800 | $15.81 | $3M |
| TNL - Travel Plus Leisure | 0.88% | Hold | 55,400 | $55.27 | $3M |
| SFIX - Stitch Fix · CL A | 0.88% | Hold | 160,500 | $18.92 | $3M |
| Karuna Therapeutics | 0.72% | Hold | 19,200 | $130.99 | $3M |
| REAL - The Realreal | 0.58% | Hold | 173,500 | $11.61 | $2M |
| PGEN - Precigen | 0.32% | Hold | 298,200 | $3.71 | $1M |
Filings history
19 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 40 | $3.1B | +11.5% | 13F-HR | 8/13/2026 | 000185479426000005 |
| 2026 Q1 | 40 | $2.7B | +5.6% | 13F-HR | 5/14/2026 | 000185479426000004 |
| 2025 Q4 | 40 | $2.6B | +3.7% | 13F-HR | 2/13/2026 | 000185479426000003 |
| 2025 Q3 | 41 | $2.5B | +12.7% | 13F-HR | 10/30/2025 | 000185479425000004 |
| 2025 Q2 | 40 | $2.2B | +13.9% | 13F-HR | 8/13/2025 | 000108514625004963 |
| 2025 Q1 | 39 | $1.9B | −10.2% | 13F-HR | 5/14/2025 | 000108514625003124 |
| 2024 Q4 | 43 | $2.2B | +6.4% | 13F-HR | 2/14/2025 | 000108514625001553 |
| 2024 Q3 | 41 | $2B | +8.2% | 13F-HR | 11/14/2024 | 000108514624005800 |
| 2024 Q2 | 40 | $1.9B | −8.3% | 13F-HR | 8/14/2024 | 000108514624003874 |
| 2024 Q1 | 42 | $2.1B | +8.8% | 13F-HR | 5/15/2024 | 000108514624002548 |
| 2023 Q4 | 43 | $1.9B | +10.8% | 13F-HR | 2/14/2024 | 000108514624001375 |
| 2023 Q3 | 42 | $1.7B | −5.2% | 13F-HR | 11/14/2023 | 000108514623004442 |
| 2023 Q2 | 44 | $1.8B | +702.2% | 13F-HR | 8/14/2023 | 000108514623003400 |
| 2023 Q1 | 42 | $224M | +8.7% | 13F-HR | 5/15/2023 | 000108514623002385 |
| 2022 Q4 | 43 | $206M | +3.0% | 13F-HR | 2/14/2023 | 000108514623001252 |
| 2022 Q3 | 42 | $200M | −11.5% | 13F-HR | 11/14/2022 | 000108514622004043 |
| 2022 Q2 | 42 | $226M | −23.4% | 13F-HR | 8/15/2022 | 000108514622003092 |
| 2022 Q1 | 45 | $295M | −15.0% | 13F-HR | 5/16/2022 | 000108514622002149 |
| 2021 Q4 | 43 | $347M | — | 13F-HR | 2/14/2022 | 000108514622001017 |
About
Patient Capital Management, LLC
19 processed 13Fs on this site · 2021 Q4–2026 Q2